Oncology is shifting from the traditional one-size-fits-all cancer treatment model to a multifaceted model that takes into account the complexity and heterogeneity of the disease. This shift, termed precision oncology, is enabled by advances in genetics, genomics, proteomics, advanced data analytics, and modern molecular biology techniques such as the CRISPR/Cas9 technology. This chapter provides an overview of how these different areas have contributed to the advancement of precision oncology. Besides, it is also important to acknowledge that in isolation, the contribution of these different areas to precision oncology is limited. There is therefore a need for an integrated approach to be truly game-changing. Hence, this chapter also emphasizes the necessity for an integrated approach and interdisciplinary collaboration to advance the field of precision oncology. We also propose a few future directions, such as a stronger focus on single-cell analysis and AI-assisted research, which collectively have the potential to personalize cancer treatment to an unprecedented level. It is hoped that these integrated strategies will prevail and transform cancer care into a model characterized by precision, personalization, and compassion.